Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-007814

CHIEF OPERATING OFFICER sold 12,409 shares at $21.06 ($261,334)

  • CHIEF OPERATING OFFICER acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-03-10 Option exercise 10b5-1 +7,000 $3.80 $26,600 88,975 D
Tessari Eben CHIEF OPERATING OFFICER 2025-03-10 Sale 10b5-1 −12,409 $21.06 $261,334 76,566 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2025-03-10 Option exercise · Share Option 10b5-1 −7,000 14,049 D
Open-market sales · 12,409 sh · avg $21.06 · $261,334
Loading xslF345X05/form4-03122025_080305.xml…